Analyzes circulating cell-free DNA in blood for cancer-associated molecular signals, including DNA methylation and fragmentomic patterns, using next-generation sequencing and machine-learning algorithms.
Used as a multi-cancer early detection screening test to identify signals associated with selected cancers in people without symptoms. A positive result does not diagnose cancer and requires further clinical evaluation and confirmatory testing.
We use analytics cookies to understand how the site is used. They are only set if you accept, and we never send your test or package details to any analytics service. Privacy Policy